EdgarLookup

EMPFIELD JAMES R.

Insider transactions at 1 company

This page shows all SEC Form 4 filings attributed to EMPFIELD JAMES R.. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.

XENE
Company Title Type Shares Price Value Date
XENE EVP, Drug Discovery Option Exercise 45,000 $4.75 $213,750 Aug 12, 2022
XENE EVP, Drug Discovery Sale 31,048 $30.54 $948,206 Mar 4, 2022
XENE SVP, Drug Discovery Purchase 10,000 $2.48 $24,800 Aug 15, 2017